SUCCESSFUL COMBINED AMPHOTERICIN B AND 5-FLUOROCYTOSINE THERAPY FOR DISSEMINATED ASPERGILLOSIS IN A CASE OF NON-HODGKIN'S LYMPHOMARADAELLI F; CORTELEZZI A; POGLIANI EM et al.1981; CURR. THER. RES.; ISSN 0011-393X; USA; DA. 1981; VOL. 30; NO 4; PP. 549-560; BIBL. 17 REF.Article

OSTEOLYSIS IN CHRONIC MYELOID LEUKEMIA.LAMBERTENGHI DELILIERS G; CASTAGNONE D; PORRO F et al.1978; TUMORI; ITAL.; DA. 1978; VOL. 64; NO 2; PP. 175-181; ABS. ITAL.; BIBL. 19 REF.Article

Diagnostic role and prognostic significance of a simplified immunophenotypic classification of mature B cell chronic lymphoid leukemiasCRO, L; GUFFANTI, A; MAIOLO, A. T et al.Leukemia. 2003, Vol 17, Num 1, pp 125-132, issn 0887-6924, 8 p.Article

Interferon alfa-2b versus no maintenance therapy during the plateau phase in multiple myeloma : a randomized studyWESTIN, J; RÖDJER, S; TURESSON, I et al.British journal of haematology. 1995, Vol 89, Num 3, pp 561-568, issn 0007-1048Article

PRESENCE OF CIRCULATING IMMUNE COMPLEXES IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKAEMIA. CORRELATIONS BETWEEN CLINICAL AND IMMUNOLOGICAL FEATURESMOZZANA R; BALDINI L; NERI A et al.1982; BOLLETTINO DELL'ISTITUTO SIEROTERAPICO MILANESE; ISSN 0021-2547; ITA; DA. 1982; VOL. 61; NO 4; PP. 324-329; ABS. ITA; BIBL. 38 REF.Article

Impact of B-cell count and imaging screening in cMBL: any need to revise the current guidelines?SCARFO, L; ZIBELLIN, S; CORTELEZZI, A et al.Leukemia. 2012, Vol 26, Num 7, pp 1703-1707, issn 0887-6924, 5 p.Article

Taxonomic and nontaxonomic responses to ecological changes in an urban lowland stream through the use of Chironomidae (Diptera) larvaeCORTELEZZI, A; PAGGI, A. C; RODRIGUEZ, M et al.Science of the total environment. 2011, Vol 409, Num 7, pp 1344-1350, issn 0048-9697, 7 p.Article

Low plasma stem cell factor levels correlate with in vitro leukemic growth in myelodysplastic syndromesCORTELEZZI, A; CATTANEO, C; CRISTIANI, S et al.Leukemia research. 1999, Vol 23, Num 3, pp 271-275, issn 0145-2126Article

Interferon therapy during the plateau phase of multiple myeloma : an updtate of the Swedish studyWESTIN, J; CORTELEZZI, A; HJORTH, M et al.European journal of cancer (1990). 1991, Vol 27, pp S44-S48, issn 0959-8049, SUP4Conference Paper

Recombinant γ-interferon as first line therapy for high risk myelodysplastic syndromesMAIOLO, A. T; CORTELEZZI, A; CALORI, R et al.Leukemia. 1990, Vol 4, Num 7, pp 480-485, issn 0887-6924, 6 p.Article

Bone marrow histological modifications induced by alpha interferon in hairy cell leukemiaLAMBERTENGHI-DELILIERS, G; BENAZZI, E; CORTELEZZI, A et al.Acta haematologica. 1987, Vol 77, Num 4, pp 203-207, issn 0001-5792Article

Diagnosis and treatment of fungal infections in patients with hematologic malignanciesRADAELLI, F; CORTELEZZI, A; ZOCCHI, L et al.Hematological oncology. 1986, Vol 4, Num 2, pp 129-134, issn 0278-0232Article

In vitro production of anti-RBC antibodies and cytokines in chronic lymphocytic leukemiaBARCELLINI, W; MONTESANO, R; CLERICI, G et al.American journal of hematology. 2002, Vol 71, Num 3, pp 177-183, issn 0361-8609, 7 p.Article

Bone marrow histology and CD34 immunostaining in the prognostic evaluation of primary myelodysplastic syndromesORIANI, A; ANNALORO, C; SOLIGO, D et al.British journal of haematology. 1996, Vol 92, Num 2, pp 360-364, issn 0007-1048Article

In vitro effects of IL-2 on NK-activity, clonogenic potential, blast cell proliferation and cytokine release of MDS bone marrow patientsCORTELEZZI, A; SARINA, B; RADELLI, L et al.Leukemia. 1996, Vol 10, Num 7, pp 1181-1189, issn 0887-6924Article

Response of myelodyslastic syndrome marrow progenitor cells to stimulation with cytokine combinations in a stroma-free long-term culture systemSOLIGO, D. A; CAMPIGLIO, S; SERVIDA, F et al.British journal of haematology. 1996, Vol 92, Num 3, pp 548-558, issn 0007-1048Article

Quality control of red cell filtration at the patients's bedsideSIRCHIA, G; REBULLA, P; PARRAVICINI, A et al.Transfusion (Philadelphia, PA). 1994, Vol 34, Num 1, pp 26-30, issn 0041-1132Article

Effects of recombinant human stem cell factor (rh-SCF) on colony formation and long-term bone marrow cultures (LTBMC) in patients with myelodysplastic syndromesSOLIGO, D; SERVIDA, F; CORTELEZZI, A et al.European journal of haematology. 1994, Vol 52, Num 1, pp 53-60, issn 0902-4441Article

Duration of first remission in leukaemic recipients of leucocyte-poor blood componentsREBULLA, P; PAPPALETTERA, M; BARBUI, T et al.British journal of haematology. 1990, Vol 75, Num 3, pp 441-442, issn 0007-1048, 2 p.Article

Low-dose subcutaneous alemtuzumab in refractory chronic lymphocytic leukaemia (CLL): results of a prospective, single-arm multicentre studyCORTELEZZI, A; PASQUINI, M. C; DELILIERS, G. L et al.Leukemia. 2009, Vol 23, Num 11, pp 2027-2033, issn 0887-6924, 7 p.Article

Angiogenesis in myelodysplastic syndromesPRUNERI, G; BERTOLINI, F; SOLIGO, D et al.British journal of cancer. 1999, Vol 81, Num 8, pp 1398-1401, issn 0007-0920Article

In vitro effects of IL-12 and IL-2 on NK cells, cytokine release and clonogenic activity in myelodysplastic syndromes (MDS)SARINA, B; CORTELEZZI, A; CATTANEO, C et al.Leukemia. 1997, Vol 11, Num 10, pp 1726-1731, issn 0887-6924Article

Analysis of alterations of oncogenes and tumor suppressor genes in chronic lymphocytic leukemiaGAIDANO, G; NEWCOMB, E. W; GONG, J. Z et al.The American journal of pathology. 1994, Vol 144, Num 6, pp 1312-1319, issn 0002-9440Article

Ibarubicin in the therapy of acute myeloid leukemia : final analysis in previously untreated patientsDELILIERS, G. L; ANNALORO, C; BOSCHETTI, C et al.Seminars in oncology. 1993, Vol 20, Num 6, pp 27-33, issn 0093-7754, SUP8Article

Plasma cyclic nucleotide levels in acute leukemia patientsPERACCHI, M; TOSHI, V; BAMONTI-CATENA, F et al.Blood. 1987, Vol 69, Num 6, pp 1613-1616, issn 0006-4971Article